Publication

A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

Chat with Graph Search

Using Negative Control Populations to Assess Unmeasured Confounding and Direct Effects

Efficacy and safety of transcranial direct current stimulation to the ipsilesional motor cortex in subacute stroke (NETS): a multicenter, randomized, double-blind, placebo-controlled trial

Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection

Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy

Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma

Interventionist estimands in event history analysis

Optimised three-dimensional in vitro retinoblastoma models tailored for drug discovery and clinical translatability

Inactivation mechanisms of influenza A virus under pH conditions encountered in aerosol particles as revealed by whole-virus HDX-MS

Elucidating and modulating regulatory pathways so as to reprogram the immunosuppressive tumor microenvironment for therapeutic benefit

Rational Design of Chemically Controlled Antibodies and Protein Therapeutics

Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma

Cell-free method for the quantitative measurement of virus neutralizing antibodies

Translating questions to estimands in randomized clinical trials with intercurrent events

Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States

Temporal dynamics of intranasal oxytocin in human brain electrophysiology

Scrambler Therapy for Chronic Pain after Burns and Its Effect on the Cerebral Pain Network: A Prospective, Double-Blinded, Randomized Controlled Trial

Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients

Targeting molecular surfaces to engineer novel protein-based immunogens and inhibitors

A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

Interventions for Softening Can Lead to Hardening of Opinions: Evidence from a Randomized Controlled Trial